Search Results

You are looking at 251 - 260 of 2,734 items for :

  • Refine by Access: All x
Clear All
Full access

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice

Pamala A. Pawloski, Gabriel A. Brooks, Matthew E. Nielsen, and Barbara A. Olson-Bullis

-based standardization of cancer care, improving care delivery and patient outcomes. CDS tools have been incorporated across the patient care spectrum, encompassing prevention, diagnosis, and clinical monitoring. Common roles for CDS include computerized physician order

Full access

CLO22-047: Outcomes of SARS-COV-2 mRNA-1273 Vaccine in Cancer Patients: Seroconversion and Adverse Events

Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Alberto Delgado-Iribarren Garcia-Campero, Elvira Baos Muñoz, Sara Gil Useros, and Pedro Perez Segura

Full access

HSR20-092: “Write to Recover”: The Impact of Group Led Creative Writing on Physical Health Outcomes in Cancer Patients

Courtney Ann Kramer, Darya S. Nesterova, Junjia Zhu, Monali Vasekar, Jolene Collins, Cristina Truica, Aditya Joshi, Michael Hayes, Erika F. H. Saunders, Joseph J. Drabick, and Monika Joshi

Full access

HSR22-178: Real World Outcomes of Cancer Patients With SARS-CoV-2 Infection Receiving Monoclonal Antibodies

Alexa Wilden, Aishwarya Sannareddy, Hetal Patel, Shraddha Kansagra, Gurbakhash Kaur, Praveen Ramakrishnan, Prapti Patel, Ansh Mehta, and Ankit Kansagra

Full access

CLO21-028: Clinical Outcomes for Advanced Hepatocellular Carcinoma Patients Treated With Systemic Agents in Real-World Practice

Karine Tawagi, Diana Maslov, Madhav KC, Danny Markabawi, Suresh Mukkamala, Fady Farag, Helen Yuan, Adi Bamnolker, Rula Saeed, Zoe Blake, Marc Matrana, and Daniel Johnson

Full access

Multidisciplinary Management of Pancreatic Cancer

Margaret A. Tempero

essentially be summarized as a half dozen clinical trials evaluating gemcitabine and 5-fluorouracil (FU), with and without radiation. Outcomes from these trials were largely similar, with median OS hovering around 22 months and 25% to 30% of patients dying of

Full access

Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis

Julie Hallet, Laura Davis, Alyson Mahar, Michail Mavros, Kaitlyn Beyfuss, Ying Liu, Calvin H.L. Law, Craig Earle, and Natalie Coburn

Background As medical and surgical therapies advance, cancer care has become increasingly complex. Clinical volume is an important construct in the delivery of specialized care, and provider volume has been associated with improved outcomes of

Full access

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex

Zheng Zhou, Alfred W. Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby-Thompson, Ann Vanderplas, Gregory A. Abel, Maria A. Rodriguez, Auayporn Nademanee, Mark S. Kaminski, Myron S. Czuczman, Michael M. Millenson, Andrew D. Zelenetz, Joyce Niland, Jonathan W. Friedberg, and Jane N. Winter

Background Results of prospective clinical trials for patients with previously untreated diffuse large B-cell lymphoma (DLBCL) suggest that patient sex, weight, and/or body mass index (BMI) impact clinical outcomes. Recent reports implicate

Full access

Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis

Elliott K. Yee, Natalie G. Coburn, Laura E. Davis, Alyson L. Mahar, Victoria Zuk, Vaibhav Gupta, Ying Liu, Craig C. Earle, and Julie Hallet

outcomes for the majority of patients with noncurable disease is therefore crucial. Previous work has revealed underassessment and low treatment rates for pancreatic adenocarcinoma, with 35% of patients with advanced disease not seeing a medical oncologist

Full access

Paraneoplastic Syndromes Associated With Small Cell Lung Cancer

Leena Gandhi and Bruce E. Johnson

with ectopic corticotropin production and small-cell lung cancer . J Clin Oncol 1992 ; 10 : 21 – 27 . 17. Delisle L Boyer MJ Warr D . Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and